Identification of highly-protective combinations of Plasmodium vivax recombinant proteins for vaccine development

Download
Author
Franca, CT; White, MT; He, W-Q; Hostetler, JB; Brewster, J; Frato, G; Malhotra, I; Gruszczyk, J; Huon, C; Lin, E; ...Date
2017-09-26Source Title
eLifePublisher
ELIFE SCIENCES PUBLICATIONS LTDUniversity of Melbourne Author/s
Healer, Julie; Mueller, Ivo; Cowman, Alan; Tenorio Franca, Camila; Tham, Wai-HongAffiliation
Medical Biology (W.E.H.I.)Metadata
Show full item recordDocument Type
Journal ArticleCitations
Franca, C. T., White, M. T., He, W. -Q., Hostetler, J. B., Brewster, J., Frato, G., Malhotra, I., Gruszczyk, J., Huon, C., Lin, E., Kiniboro, B., Yadava, A., Siba, P., Galinski, M. R., Healer, J., Chitnis, C., Cowman, A. F., Takashima, E., Tsuboi, T. ,... Mueller, I. (2017). Identification of highly-protective combinations of Plasmodium vivax recombinant proteins for vaccine development. ELIFE, 6, https://doi.org/10.7554/eLife.28673.Access Status
Open AccessAbstract
The study of antigenic targets of naturally-acquired immunity is essential to identify and prioritize antigens for further functional characterization. We measured total IgG antibodies to 38 P. vivax antigens, investigating their relationship with prospective risk of malaria in a cohort of 1-3 years old Papua New Guinean children. Using simulated annealing algorithms, the potential protective efficacy of antibodies to multiple antigen-combinations, and the antibody thresholds associated with protection were investigated for the first time. High antibody levels to multiple known and newly identified proteins were strongly associated with protection (IRR 0.44-0.74, p<0.001-0.041). Among five-antigen combinations with the strongest protective effect (>90%), EBP, DBPII, RBP1a, CyRPA, and PVX_081550 were most frequently identified; several of them requiring very low antibody levels to show a protective association. These data identify individual antigens that should be prioritized for further functional testing and establish a clear path to testing a multicomponent P. vivax vaccine.
Export Reference in RIS Format
Endnote
- Click on "Export Reference in RIS Format" and choose "open with... Endnote".
Refworks
- Click on "Export Reference in RIS Format". Login to Refworks, go to References => Import References
Collections
- Minerva Elements Records [53102]
- Medical Biology - Research Publications [1415]